retatrutide triple agonist glp-1 gip glucagon receptors receptor The data just dropped β and is rewriting what's possible in obesity medicine. 𧬠TRIUMPH-1 just released Phase 3 Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 20 - Aug 25




























